What is the stellate ganglion block for coronary artery spasm, including its technique, dosage, efficacy, risks, and follow‑up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Stellate Ganglion Block for Coronary Artery Spasm

Stellate ganglion block (SGB) is a salvage intervention for refractory coronary artery spasm that has failed medical therapy with calcium channel blockers and nitrates, and should be considered as a bridge to definitive bilateral thoracoscopic sympathectomy in patients with recurrent, life-threatening episodes.

When to Consider SGB

The 2024 ESC guidelines establish that calcium channel blockers are the Class I (Level A) recommendation for isolated vasospastic angina to control symptoms and prevent potentially fatal complications 1. However, when patients remain refractory to maximal medical therapy (calcium channel blockers plus long-acting nitrates) and experience recurrent episodes threatening quality of life or survival, SGB becomes a viable option.

The most compelling recent evidence comes from a 2025 case report demonstrating successful use of unilateral SGB followed by bilateral thoracoscopic sympathectomy in a 42-year-old with recurrent coronary artery spasm secondary to eosinophilic asthma, with no subsequent recurrence 2. This represents the definitive treatment pathway for truly refractory cases.

Technique

Ultrasound-guided approach is the current standard:

  • Target the stellate ganglion (cervicothoracic ganglion) at the C6 or C7 level
  • Use 1% lidocaine hydrochloride as the local anesthetic 3
  • Perform unilateral block initially; bilateral blocks can be done if needed
  • Confirmation of successful blockade: ipsilateral Horner syndrome (ptosis, miosis, anhidrosis) 3

The ultrasound-guided technique has replaced landmark-based approaches, improving safety and efficacy 4.

Dosage and Medications

  • Local anesthetic: 1% lidocaine hydrochloride (volume typically 5-10 mL, though specific volumes vary by technique) 3
  • The block provides temporary sympathetic inhibition lasting hours to days
  • Repeat blocks may be necessary while arranging definitive surgical sympathectomy

Efficacy

SGB demonstrates high immediate efficacy for sympathetically-mediated cardiac events:

  • 100% success rate in terminating refractory arrhythmias in recent case series 3
  • Successful prevention of recurrent coronary spasm when used as bridge to sympathectomy 2
  • The mechanism works by inhibiting sympathetic outflow, modulating vasodilation and regional perfusion, and attenuating stress responses 4

Critical caveat: SGB is a temporizing measure, not definitive therapy. For recurrent coronary artery spasm, plan for bilateral thoracoscopic sympathectomy as the definitive intervention 2.

Risks and Complications

Common and expected:

  • Horner syndrome (desired endpoint confirming successful block) 3

Potential serious complications to monitor:

  • Pneumothorax
  • Vascular puncture/hematoma
  • Recurrent laryngeal nerve block (hoarseness)
  • Phrenic nerve block (hemidiaphragm paralysis)
  • Intravascular injection
  • Epidural/spinal spread

Important consideration: The procedure can be performed safely even in high-risk patients with multiple comorbidities, including those on anticoagulation, recent MI, or cardiac conduction abnormalities 5. However, careful risk-benefit assessment is mandatory.

Patient Selection Algorithm

  1. First-line: Calcium channel blockers ± long-acting nitrates (Class I recommendation) 1
  2. Confirm diagnosis: Invasive coronary angiography with provocative testing if diagnosis uncertain 1
  3. Refractory symptoms: If recurrent episodes despite maximal medical therapy
  4. Consider SGB: For life-threatening recurrent spasm or as bridge to surgery
  5. Definitive therapy: Bilateral thoracoscopic sympathectomy for sustained control 2

Follow-Up

  • Immediate: Monitor for Horner syndrome to confirm successful block
  • 24-hour observation: Assess for arrhythmia recurrence and procedure complications 3
  • Short-term: Arrange cardiac sympathectomy consultation if spasm recurs
  • Long-term: After sympathectomy, continue calcium channel blockers as maintenance therapy

Critical Pitfalls to Avoid

Do not use non-selective beta-blockers in vasospastic angina—they can worsen spasm by allowing unopposed alpha-adrenergic vasoconstriction 6.

Do not assume absence of ST elevation rules out spasm—many patients with confirmed coronary spasm on provocative testing do not show ST elevation on ambulatory monitoring or even during chest pain 7.

Do not perform SGB as first-line therapy—it is reserved for refractory cases after guideline-directed medical therapy has failed 1, 2.

The evidence base for SGB in coronary spasm remains limited to case reports and small series, but the intervention shows promise as a bridge to definitive surgical sympathectomy in carefully selected patients with truly refractory disease 2, 4.

References

Related Questions

In a patient with documented coronary artery spasm refractory to calcium‑channel blockers and nitrates, is a stellate ganglion block indicated, and what are the recommended technique and monitoring?
What are the non‑ischemic causes of angina, such as coronary artery spasm?
Are beta‑blockers indicated for an acute coronary syndrome ST‑segment elevation myocardial infarction caused by coronary vasospasm?
What does a finding of possible vasospasm on CT perfusion (CTP) indicate?
What is the surgical sympathectomy (thoracoscopic) for a patient with coronary artery spasm refractory to maximal calcium‑channel blockers, nitrates, and alpha‑blockers?
Does consuming protein above 1.2 g per kilogram of body weight per day provide additional muscle‑mass benefits, or does metabolic adaptation blunt the anabolic response?
What is the appropriate management for a 3‑year‑old female who experiences immediate abdominal pain after any oral intake, has a history of constipation, a recent self‑limited episode of diarrhea, and a resolved fever and vomiting, with normal vitals, bowel sounds, and no abdominal tenderness?
What is the appropriate dosing regimen for chronic constipation in an adult?
What are the appropriate treatment options for cyclothymic disorder in a patient currently taking sertraline, quetiapine, and prazosin for PTSD-related nightmares?
What caloric intake is required for an active adult before determining appropriate protein recommendations?
Given that the patient's blood pressure increased from 118/60 mmHg to 154/90 mmHg, should we continue clonidine 0.1 mg twice daily and losartan 25 mg daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.